Open Access. Powered by Scholars. Published by Universities.®
Other Analytical, Diagnostic and Therapeutic Techniques and Equipment Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Keyword
-
- Antihypertensive drugs; Green assessment; Hydrochlorothiazide; Nebivolol; RP-HPLC; Valsartan (1)
- Dapagliflozin; drug repurposing; gliflozins; neuroprotective antidiabetics (1)
- Enhanced extraction; human plasma; human volunteers; LC-MS/MS; omarigliptin (1)
- Forced degradation; Ipragliflozin; MS/MS; UPLC; Validation (1)
- Keywords: repurposing; omarigliptin; docking; A2A adenosine receptor; acetylcholine esterase receptor; GLP-1; rats’ plasma; rats’ brain tissue; 28 days multiple doses; LC-MS/MS (1)
Articles 1 - 6 of 6
Full-Text Articles in Other Analytical, Diagnostic and Therapeutic Techniques and Equipment
Development Of Rp-Hplc Method For Simultaneous Determination Of Nebivolol Hydrochloride, Valsartan And Hydrochlorothiazide In Co-Administrated Antihypertensive Agents And Human Plasma, Shereen Mowaka, M. Rizk, Maha M. Abou El‐Alamin, Mariam Mohamed
Development Of Rp-Hplc Method For Simultaneous Determination Of Nebivolol Hydrochloride, Valsartan And Hydrochlorothiazide In Co-Administrated Antihypertensive Agents And Human Plasma, Shereen Mowaka, M. Rizk, Maha M. Abou El‐Alamin, Mariam Mohamed
Pharmacy
Reversed phase high performance liquid chromatography combined with photodiode array (HPLC-PDA) detector method was developed for simultaneous determination of two binary antihypertensive combinations; either Nebivolol (NEB) with Hydrochlorothiazide (HCZ) or with Valsartan (VAL) in pharmaceutical formulation and spiked human plasma. The method was successfully applied to separate the three drugs on one chromatogram under the same chromatographic conditions that used for two binary combinations. The separation was established on Xterra C18 column using gradient mobile phase which composed of acidified water of pH = 3.0 (adjusted with 0.1% orthophosphoric acid) and acetonitrile with flow rate of 1.0 mL/min. The drugs …
The Potential Off-Target Neuroprotective Effect Of Sister Gliflozins Suggests Their Repurposing Despite Not Crossing The Blood–Brain Barrier: From Bioanalytical Assay In Rats Into Theory Genesis, Shereen Mowaka, Moataz S. Hendy, Ehab F. Elkady, Asmaa El-Zaher, Bassam M. Ayoub
The Potential Off-Target Neuroprotective Effect Of Sister Gliflozins Suggests Their Repurposing Despite Not Crossing The Blood–Brain Barrier: From Bioanalytical Assay In Rats Into Theory Genesis, Shereen Mowaka, Moataz S. Hendy, Ehab F. Elkady, Asmaa El-Zaher, Bassam M. Ayoub
Pharmacy
Gliflozins are successfully marketed antidiabetic agents with a reported neuroprotective effect, and this study tests their blood–brain barrier crossing ability. Henceforward, a computational hypothesis interpreting their effects was reasonable after failure to cross into the brain. A chromatographic bioassay for canagliflozin, dapagliflozin, and empagliflozin was developed, validated, and applied to the rat's and rat's plasma and brain. HPLC method robustness was tested over two levels using Design of Experiment on MINITAB. It is the first method for gliflozins’ detection in rats’ brain tissue. The method was applied on 18 rats and six for each drug. Concentrations in plasma were determined …
Kinetic Degradation Study Of Ipragliflozin Coupled With Ms/Ms Structural Elucidation, Shereen Mowaka, Manar M. Elhassan,, Amr M. Mahmoud, Maha A. Hegazy
Kinetic Degradation Study Of Ipragliflozin Coupled With Ms/Ms Structural Elucidation, Shereen Mowaka, Manar M. Elhassan,, Amr M. Mahmoud, Maha A. Hegazy
Pharmacy
Ipragliflozin degradation behavior was studied under different conditions: acidic, basic, photolytic, oxidative and thermal degradation conditions. This forced degradation study showed the extensive degradation of Ipragliflozin under acidic, basic and oxidative conditions while showed high stability under thermal and photo-degradation conditions. The separation of Ipragliflozin and its degradation products was done using Hypersil Gold® UPLC C18 column with 1.9 μm particle size (3 × 50 mm) as stationary phase and a mobile phase composed of acetonitrile: potassium monobasic phosphate buffer pH 3 (50:50; v/v) delivered at flow rate of 0.6 mL min−1. Validation of the proposed method was carried out …
Repurposing Of Omarigliptin As A Neuroprotective Agent Based On Docking With A2a Adenosine And Ache Receptors, Brain Glp-1 Response And Its Brain/Plasma Concentration Ratio After 28 Days Multiple Doses In Rats Using Lc-Ms/Ms, Bassam Ayoub, Haidy Michel, Shereen Mowaka, Moataz S. Hendy, Mariam M. Tadros
Repurposing Of Omarigliptin As A Neuroprotective Agent Based On Docking With A2a Adenosine And Ache Receptors, Brain Glp-1 Response And Its Brain/Plasma Concentration Ratio After 28 Days Multiple Doses In Rats Using Lc-Ms/Ms, Bassam Ayoub, Haidy Michel, Shereen Mowaka, Moataz S. Hendy, Mariam M. Tadros
Pharmacy
Abstract: The authors in the current work suggested the potential repurposing of omarigliptin (OMR) for neurodegenerative diseases based on three new findings that support the preliminary finding of crossing BBB after a single dose study in the literature. The first finding is the positive results of the docking study with the crystal structures of A2A adenosine (A2AAR) and acetylcholine esterase (AChE) receptors. A2AAR is a member of non-dopaminergic GPCR superfamily receptor proteins and has essential role in regulation of glutamate and dopamine release in Parkinson’s disease while AChE plays a major role in Alzheimer’s disease as the primary enzyme responsible …
Enhanced Extraction Technique Of Omarigliptin From Human Plasma-Applied To Biological Samples From Healthy Human Volunteers, Shereen Mowaka, Nermeen Ashoush, Mariam M. Tadros, Noha M. Elzahar, Bassam Ayoub
Enhanced Extraction Technique Of Omarigliptin From Human Plasma-Applied To Biological Samples From Healthy Human Volunteers, Shereen Mowaka, Nermeen Ashoush, Mariam M. Tadros, Noha M. Elzahar, Bassam Ayoub
Pharmacy
Enhancing drug extraction from human plasma is a challenging approach that critically affects pharmacokinetic and any further clinical studies based on the drug Cmin and Cmax values. It also has a serious impact on the sensitivity and the lower limit of quantification (LLOQ) value of the bio-analytical methods. An advanced liquid chromatography tandem mass spectrometry (LC-MS/MS) bio-analytical method of omarigliptin (25–1000 nM) was established in human plasma using one-step liquid-liquid extraction. Alogliptin was used as an internal standard (IS) to attain good recovery and reproducibility while reducing the effects of the matrix. Enhanced plasma extraction of omarigliptin was successfully achieved …
Uplc Simultaneous Determination Of Empagliflozin, Linagliptin And Metformin, Bassam M. Ayoub
Uplc Simultaneous Determination Of Empagliflozin, Linagliptin And Metformin, Bassam M. Ayoub
Pharmacy
© The Royal Society of Chemistry. The first UPLC method for simultaneous determination of empagliflozin, linagliptin and metformin hydrochloride in the different combinations of their pharmaceutical dosage forms was developed. Chromatographic separation was achieved on a Symmetry® Acclaim™ RSLC 120 C18 column (100 mm × 2.1 mm, 2.2 μm) applying isocratic elution based on potassium dihydrogen phosphate buffer pH (4)-methanol (50 : 50, v/v) as the mobile phase. The linearity, accuracy and precision were found to be acceptable over the concentration ranges of 1-32 μg mL-1, 0.5-16 μg mL-1 and 1-100 μg mL-1 for empagliflozin, linagliptin and metformin hydrochloride, respectively. …